Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma

被引：0
|
作者：
Henrique A. Lima
Yutaka Endo
Laura Alaimo
Zorays Moazzam
Muhammad Musaab Munir
Chanza Shaikh
Vivian Resende
Alfredo Guglielmi
Hugo P. Marques
François Cauchy
Vincent Lam
George A. Poultsides
Irinel Popescu
Sorin Alexandrescu
Guillaume Martel
Tom Hugh
Itaru Endo
Minoru Kitago
Feng Shen
Timothy M. Pawlik
机构：
[1] The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center,Department of Surgery
[2] Federal University of Minas Gerais School of Medicine,Department of Surgery
[3] University of Verona,Department of Surgery
[4] Curry Cabral Hospital,Department of Hepatibiliopancreatic Surgery
[5] APHP,Department of Surgery
[6] Beaujon Hospital,Department of Surgery
[7] Westmead Hospital,Department of Surgery
[8] Stanford University,Department of Surgery
[9] Fundeni Clinical Institute,Department of Surgery, School of Medicine
[10] University of Ottawa,Department of Surgery
[11] The University of Sydney,undefined
[12] Yokohama City University School of Medicine,undefined
[13] Keio University,undefined
[14] Eastern Hepatobiliary Surgery Hospital,undefined
来源：
Journal of Gastrointestinal Surgery | 2022年 / 26卷
关键词：
Intermediate-stage hepatocellular carcinoma; BCLC B; Tumor burden score; Alpha-fetoprotein; Multi-institutional database;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2512 / 2521
页数：9
相关论文
共 50 条
  • [1] Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma
    Lima, Henrique A.
    Endo, Yutaka
    Alaimo, Laura
    Moazzam, Zorays
    Munir, Muhammad Musaab
    Shaikh, Chanza
    Resende, Vivian
    Guglielmi, Alfredo
    Marques, Hugo P.
    Cauchy, Francois
    Lam, Vincent
    Poultsides, George A.
    Popescu, Irinel
    Alexandrescu, Sorin
    Martel, Guillaume
    Hugh, Tom
    Endo, Itaru
    Kitago, Minoru
    Shen, Feng
    Pawlik, Timothy M.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (12) : 2512 - 2521
  • [2] Alpha-fetoprotein response following transarterial chemoembolization indicates improved survival for intermediate-stage hepatocellular carcinoma
    Liu, Guanghua
    Ouyang, Qiang
    Xia, Fang
    Fan, Guoping
    Yu, Juming
    Zhang, Caiyuan
    Wang, Dengbin
    HPB, 2019, 21 (01) : 107 - 113
  • [3] Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein
    Lee, Jin-Chiao
    Hung, Hao-Chien
    Wang, Yu-Chao
    Cheng, Chih-Hsien
    Wu, Tsung-Han
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Chan, Kun-Ming
    Lee, Wei-Chen
    CANCERS, 2021, 13 (17)
  • [4] Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma
    Kitao, S
    Yamada, T
    Ishikawa, T
    Madarame, H
    Furuichi, M
    Neo, S
    Tsuchiya, R
    Kobayashi, K
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2006, 18 (03) : 291 - 295
  • [5] SERUM ALPHA-FETOPROTEIN IN THE EARLY STAGE OF HUMAN HEPATOCELLULAR-CARCINOMA
    CHEN, DS
    SUNG, JL
    SHEU, JC
    LAI, MY
    HOW, SW
    HSU, HC
    LEE, CS
    WEI, TC
    GASTROENTEROLOGY, 1984, 86 (06) : 1404 - 1409
  • [6] SERUM ALPHA-FETOPROTEIN AS A BIOCHEMICAL MARKER FOR HEPATOCELLULAR CARCINOMA
    MCINTIRE, KR
    PRINCLER, GL
    VOGEL, CL
    PATEL, IR
    CANCER RESEARCH, 1972, 32 (09) : 1941 - &
  • [7] Alpha-fetoprotein and hepatocellular carcinoma
    Colli, Agostino
    Fraquelli, Mirella
    Conte, Dario
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (08): : 1939 - 1939
  • [8] The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma
    Lu, Yan
    Lin, Bo
    Li, Mengsen
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma
    Yen, Yi-Hao
    Liu, Yueh-Wei
    Li, Wei-Feng
    Wang, Chih-Chi
    Yong, Chee-Chien
    Lin, Chih-Che
    Lin, Chih-Yun
    CANCERS, 2023, 15 (04)
  • [10] FAIL-T (ALPHA-FETOPROTEIN, AST, TUMOR SIZE, ALT, AND TUMOR NUMBER): A MODEL TO PREDICT INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA PATIENTS WHO ARE NOT A GOOD CANDIDATE FOR TACE
    Kaewdech, Apichat
    Chamroonkul, Naichaya
    Jandee, Sawangpong
    Wetwittayakhlang, Panu
    Piratvisuth, Teerha
    Sripongpun, Pimsiri
    GASTROENTEROLOGY, 2022, 162 (07) : S1157 - S1157
12345